Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 1998

View Archived Issues

Dornier's BPH device approved by FDA

Biomira updates shareholders at annual general meeting

Aastrom Biosciences receives SBIR grant for dendritic cell expansion technology research

Argonex raises funds for cancer vaccine programs

Dura and Spiros provide development update on asthma products

Urinary reflux product enters phase III

Genome Therapeutics reaches milestone in Schering-Plough alliance

Initiation of late-stage Avicine clinical trial

Access and Block Drug sign agreement for international rights to amlexanox

Molecules to Market changes name

Sertoli Technologies issued second U.S. patent for Sertoli-based cell therapies

Hemosol advances blood substitute in clinical studies for several indications

Procept's PRO-2000 gel protects against herpes infection in mice

Flavopiridol induces apoptosis, regression of human hematological malignancies

17beta-HSD type 1 inhibitors: a new treatment option for hormone-dependent breast cancer

Abbott and Boehringer Ingelheim sign comarketing agreement

PNU-151774E, a safe and effective anticonvulsant in preclinical testing

Procter & Gamble R&D on metalloprotease inhibition

Perimidine-based CRF antagonists developed at Agouron

BMS prepares novel sulfenamide taxane derivatives

Byk Gulden patents another series of thiazole PDE IV inhibitors

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

Lactadherin protects against symptomatic rotavirus infection in infants

No-approval recommendation given for AD-32 by FDA advisory committee

Large U.S. trial confirms high efficacy rate of mifepristone + misoprostol in early pregnancy

Rebetron now available in the U.S.

U.K. launch of Zoladex for assisted conception

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...